| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 206 | 5.218 | 19.040 | 52.338 | 33.401 | 28.524 | 37.612 |
| Total Income - EUR | - | - | - | 206 | 5.218 | 19.040 | 52.339 | 33.402 | 28.525 | 37.614 |
| Total Expenses - EUR | - | - | - | 2.414 | 3.897 | 10.927 | 28.249 | 23.883 | 22.838 | 33.551 |
| Gross Profit/Loss - EUR | - | - | - | -2.208 | 1.321 | 8.113 | 24.090 | 9.519 | 5.687 | 4.063 |
| Net Profit/Loss - EUR | - | - | - | -2.214 | 1.164 | 7.752 | 23.577 | 9.236 | 5.445 | 2.957 |
| Employees | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Urodent Sova Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 13.058 | 16.439 | 20.163 | 10.541 | 23.443 | 20.300 | 35.560 |
| Current Assets | - | - | - | 870 | 2.130 | 7.807 | 55.154 | 22.438 | 4.850 | 5.788 |
| Inventories | - | - | - | 0 | 1.092 | 5.960 | 1.163 | 2.305 | 1.417 | 191 |
| Receivables | - | - | - | 0 | 0 | 0 | 51.377 | 18.908 | 2.146 | 160 |
| Cash | - | - | - | 870 | 1.039 | 1.847 | 2.613 | 1.225 | 1.288 | 5.438 |
| Shareholders Funds | - | - | - | -2.171 | -965 | 6.805 | 23.619 | 9.609 | 7.114 | 3.005 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 17.991 | 21.388 | 21.164 | 42.075 | 36.273 | 18.036 | 38.343 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Urodent Sova Med S.r.l.